Changchun Bcht Biotechnology Co. Class ASSE: 688276

Announcement on Voluntary Disclosure of Approval of Marketing Authorization Application for Live Attenuated Nasal-Spray Influenza Vaccine

· Issued by Changchun Bcht Biotechnology Co. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Approval of Marketing Authorization Application for Live Attenuated Nasal-Spray Influenza Vaccine

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment